Orgad Laub
Vorstandsvorsitzender bei Sealantium Medical Ltd.
Aktive Positionen von Orgad Laub
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Rimonyx Pharmaceuticals Ltd.
 Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Direktor/Vorstandsmitglied | - | - |
Sealantium Medical Ltd.
 Sealantium Medical Ltd. Medical SpecialtiesHealth Technology Sealantium Medical Ltd. develops a biodegradable bandage for the control of hemorrhage (bleeding), used in first aid, field trauma care, and surgery. The company was founded by Orgad Laub in 2011 and is headquartered in Netanya, Israel. | Vorstandsvorsitzender | 01.01.2011 | - |
| Gründer | 01.01.2011 | - |
Karriereverlauf von Orgad Laub
Ehemalige bekannte Positionen von Orgad Laub
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Serono Corp. | Direktor/Vorstandsmitglied | - | - |
| Weizmann Institute of Science | Corporate Officer/Principal | - | - |
Statistik
International
| Israel | 5 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Rimonyx Pharmaceuticals Ltd.
Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Health Technology |
| Serono Corp. | |
Sealantium Medical Ltd.
Sealantium Medical Ltd. Medical SpecialtiesHealth Technology Sealantium Medical Ltd. develops a biodegradable bandage for the control of hemorrhage (bleeding), used in first aid, field trauma care, and surgery. The company was founded by Orgad Laub in 2011 and is headquartered in Netanya, Israel. | Health Technology |
- Börse
- Insiders
- Orgad Laub
- Erfahrung
